子宫恶性混合性苗勒管肿瘤与子宫内膜癌的分期MRI鉴别:动态增强特征重点分析
回顾性纳入37例子宫恶性混合性苗勒管肿瘤(MMMT)和42例子宫内膜癌(EC)患者,分析分期盆腔MRI动态增强特征。MMMT较EC体积更大、肿瘤脱垂率更高、强化更不均匀,延迟期出现等或高强化,PEI比值更高、SER更低;MRI增强模式可用于鉴别两者。
要点
- MMMT较EC体积更大、肿瘤脱垂更常见、强化更不均匀。
- 延迟期100%的EC信号低于子宫肌层,而仅84%的MMMT信号低于子宫肌层。
- PEI比值≥0.67预测MMMT的敏感度76%、特异度84%、AUC 0.83。
核心结论
- MMMT与EC相比可能更常出现肿瘤脱垂、更不均匀强化、延迟期等或高强化、更高的PEI比值和更低的SER;MRI可基于强化模式作为鉴别MMMT与EC的生物标志物。
研究设计与样本
- 回顾性研究,纳入37例经组织学证实、未接受治疗的子宫MMMT患者和42例未接受治疗的EC患者,均为本机构治疗;采用分期盆腔MRI,测量肿瘤大小、是否脱垂通过宫颈口等特征,并对肿瘤及周围子宫肌层感兴趣区生成时间-强度曲线,测量PEI、MSI和SER。
关键影像表现/征象
- MMMT较EC体积更大,肿瘤脱垂率更高,肿瘤强化更不均匀。
- 延迟期增强时,100%的EC信号强度低于子宫肌层,而仅84%的MMMT信号强度低于子宫肌层。
诊断标准与关键数值
- PEI比值阈值≥0.67预测MMMT:敏感度76%,特异度84%,AUC 0.83。
- SER阈值≤125预测MMMT:敏感度90%,特异度50%,AUC 0.72。
临床应用与阅片要点
- 阅片时可关注肿瘤大小、是否脱垂通过宫颈口及强化均匀性,MMMT可能表现为更大、更常脱垂且强化更不均匀。
- 可测量PEI比值和SER,PEI比值≥0.67或SER≤125时提示MMMT可能,但需注意SER特异度较低(50%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine whether staging pelvic magnetic resonance imaging (MRI) can distinguish malignant mixed Müllerian tumor (MMMT) from EC.
METHODS: Thirty-seven treatment-naïve patients with histologically proven uterine MMMT and 42 treatment-naïve patients with EC, treated at our institution, were included in our retrospective study. Staging pelvic MRI scans were reviewed for tumor size, prolapse through cervical os, and other features. Time-intensity curves for tumor and surrounding myometrium regions of interest were generated, and positive enhancement integral (PEI), maximum slope of increase (MSI), and signal enhancement ratio (SER) were measured. The Fisher's exact test or Wilcoxon rank-sum test was used to compare characteristics between disease groups. Multivariate and univariate logistic regression models were used to distinguish MMMT from EC. Receiver operating characteristic analysis and the area under the curve (AUC) were used to evaluate prediction ability.
RESULTS: MMMTs were larger than ECs with higher rate of tumor prolapse and more heterogeneous tumor enhancement compared to ECs. During the late phase of contrast enhancement, 100% of ECs, but only 84% of MMMTs, had lower signal intensity than the myometrium. Threshold PEI ratio ≥ 0.67 predict MMMT with 76% sensitivity, 84%, specificity and 0.83 AUC. Threshold SER ≤ 125 predict MMMT with 90% sensitivity, 50% specificity, and 0.72 AUC.
CONCLUSION: MMMTs may show more frequent tumor prolapse, more heterogeneous enhancement, delayed iso- or hyper-enhancement, higher PEI ratios, and lower tumor SERs compared with EC. MRI can be used as a biomarker to distinguish MMMT from EC based on the enhancement pattern.
引用
- Garza A, Elsherif SB, Faria SC, et al. Staging MRI of uterine malignant mixed Müllerian tumors versus endometrial carcinomas with emphasis on dynamic enhancement characteristics. Abdom Radiol (NY). 2020. PMID: 31190089. doi:10.1007/s00261-019-02096-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。